Is Human Metapneumovirus the Start of Pandemic 2.0 in China?

Recent reports from Taiwanese sources and Chinese opposition representatives indicate the emergence of a new virus in China, overwhelming hospitals. The virus, named Human Metapneumovirus (HMPV), reportedly has a mortality rate of 43%.

The virus particularly affects individuals under the age of 14, aligning with conspiracy theories about a new “pandemic of children.”

Although there are no widespread videos from China similar to those from 2020, some new footage has surfaced.

One video shows a distraught man jumping out of a hospital window, running on the roof, and shouting for help, claiming that they want to kill him. This incident occurred in Xianyou County, Putian City, Fujian Province, China, on December 26, 2024.

Comments suggest that this man was sentenced to an organ transplant by authorities, but a kind nurse warned him, prompting his escape attempt.

The history of transplantology dates back to before 1967. However, if these pioneers knew how their work would be used, they might have chosen a different path, perhaps focusing on virology instead.

It raises questions about the potential for a new pandemic and the ethical implications of medical advancements.

Rising Cases of Human Metapneumovirus (HMPV): A Potential Health Crisis

The number of Human Metapneumovirus (HMPV) cases is on the rise, with therapists warning that it could lead to hospitalizations and severe illness comparable to influenza and coronavirus.

Symptoms of HMPV include cough, fever, nasal congestion, and shortness of breath. Clinical symptoms can progress to bronchitis or pneumonia.

Currently, there is no specific antiviral therapy for HMPV. The virus spreads through coughing, sneezing, and contact such as shaking hands.

Identified in 2001, HMPV has been infecting humans for at least half a century. This RNA virus, like the related Human Respiratory Syncytial Virus (HRSV), poses a risk to immunocompromised individuals, particularly children and the elderly.

HMPV is responsible for about 10% of all respiratory infections, typically causing mild illnesses. However, complications can arise in vulnerable populations.

“It’s interesting because HRSV was discovered in 1953, yet we still lack a vaccine. The virus suppresses the innate immune response and can repeatedly infect individuals,” noted Professor of Virology Jianrong Li.

“We now have a mutant strain of HMPV that can trigger a stronger immune response. We’re working on a proof-of-concept to see if it works for HRSV as well.”